tiprankstipranks
Moderna (MRNA)
:MRNA
US Market

Moderna (MRNA) Technical Analysis

Compare
17,006 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -0.49, suggesting Moderna is a Sell.
Moderna’s (MRNA) 20-Day exponential moving average is 33.84, while Moderna’s (MRNA) share price is $32.66, making it a Sell.
Moderna’s (MRNA) 50-Day exponential moving average is 35.97, while Moderna’s (MRNA) share price is $32.66, making it a Sell.

Moderna (MRNA) Pivot Points

Mar 24, 2025, 03:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
30.61
31.52
31.99
32.90
33.37
34.28
34.75
Fibonacci
31.52
32.05
32.38
32.90
33.43
33.76
34.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Mar 24, 2025, 03:12 PM
Period
Simple
Exponential
MA5
33.39Sell
33.20Sell
MA10
34.06Sell
33.56Sell
MA20
33.46Sell
33.84Sell
MA50
35.28Sell
35.97Sell
MA100
39.63Sell
43.62Sell
MA200
66.92Sell
67.30Sell
Moderna’s (MRNA) 10-Day exponential moving average is 33.56, while Moderna’s (MRNA) share price is $32.66, making it a Sell.
Moderna’s (MRNA) 100-Day exponential moving average is 43.62, while Moderna’s (MRNA) share price is $32.66, making it a Sell.
Moderna’s (MRNA) stock price is $32.66 and Moderna’s (MRNA) 50-day simple moving average is 35.28, creating a Sell signal.
Moderna’s (MRNA) stock price is $32.66 and Moderna’s (MRNA) 100-day simple moving average is 39.63, creating a Sell signal.
Moderna’s (MRNA) stock price is $32.66 and Moderna’s (MRNA) 200-day simple moving average is 66.92, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Mar 24, 2025, 03:12 PM
Name
Value
Implied Action
RSI (14)
44.51
Neutral
STOCH (9,6)
10.06
Buy
STOCHRSI (14)
39.45
Neutral
MACD (12,26)
-0.49
Sell
ADX (14)
13.48
Buy
Williams %R
-62.26
Buy
CCI (14)
-65.01
Neutral
ATR (14)
2.22
-
Ultimate Oscillator
34.49
Neutral
ROC
7.90
Buy
Moderna’s (MRNA) Relative Strength Index (RSI) is 44.51, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 13.48, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is -65.01, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is 7.90, creating a Buy signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Sell.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 44.51, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is -0.49, which suggests MRNA is a Sell.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 33.39, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 33.46, which suggests MRNA is a Sell.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 35.28, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 66.92, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -62.26, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is -65.01, which suggests MRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis